Skip to content

SACCT-DM

Examination of the usefulness of a health guidance purogram for diabetic patients with obesity:Pirot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1060210053
Enrollment
12
Registered
2021-11-27
Start date
2022-01-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes Type 2 diabetes

Interventions

Patients self learn using the Health Guidance Program(SACCT Diabetes). Medical staff guide and encourage patients in multiple occupations on the occasion of consultation. In addition, when the patient

Sponsors

Shikata Kenichi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient meets all three criteria. 1) Patients with diabetes over 20 years old, HbA1c 6.5% or more, less than 10%, BMI 25 or more, less than 35 2) Patients who have been briefed, understood, and given written consent to participate in the study 3) Outpatient

Exclusion criteria

Exclusion criteria: Patients who fall under any of the four are excluded. 1) Patients who are restricted from exercising by a doctor or who have neuropathy that interferes with exercising 2) Patients with a history of myocardial infarction or cerebral infarction 3) Patients with a history of hospital visits or treatment for psychiatric disorders such as depression and schizophrenia 4) In addition, patients who are judged to be inappropriate as research subjects by the principal investigator or the research coordinator

Design outcomes

Primary

MeasureTime frame
Before and after the program, a questionnaire to measure patient satisfaction will be conducted and scored for evaluation. The patient satisfaction survey uses the Diabetes Treatment Satisfaction Questionnaire (DTSQ) verified by Ishii et al.

Secondary

MeasureTime frame
(1) Conduct a questionnaire to measure stress coping ability (psychological flexibility) before and after the program, and evaluate it by scoring it. To evaluate stress coping ability (psychological flexibility), we use a scale (Japanese version of Acceptance and Action Questionnaire-II (7 item version)) that measures avoidance of experiences verified by Shima et al. (2) Measure the weight of at each visit and the abdominal circumference at the start and end of the program. These are indexes for evaluating the therapeutic effect in clinical practice. (3) As a blood biochemical test, check HbA1c, triglyceride, HDL cholesterol, LDL cholesterol, and total cholesterol. These utilize test data performed in clinical practice.

Contacts

Public ContactSachiko Takatori

Okayama University Hospital

takato-s@okayama-u.ac.jp+81-86-235-7209

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026